Stage IV Adult Lymphoblastic Lymphoma Completed Phase 3 Trials for Daunorubicin (DB00694)

IndicationStatusPhase
DBCOND0028716 (Stage IV Adult Lymphoblastic Lymphoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs